Fig 1: Schematic diagram of pro-metastatic function of miR-4646-5p/ABHD16A/lyso-PS axis in Drosha-low expressed gastric tumor.In Drosha-low expressed gastric cancer cells, mirtronic miR-4646-5p was abnormally up-regulated. The Elevated mirtronic miR-4646-5p is a specific splicing product of intron-3 of the host gene Abhd16a with the aid of enhanced SRSF2. The enhanced miR-4646-5p can mitigate ubiquitination of HIF1A by inhibiting the target gene PHD3, thus lead to an increased HIF1A. As a transcription factor, HIF1A feedback promotes the expressions of the host gene Abhd16a and miR-4646-5p itself. The Abhd16a encodes a lipase enzyme ABHD16A, which causes accumulation of lipid metabolite lyso-PS, and then activates RhoA through GPR34/Gi. As synergistic regulation, miRNA-4646-5p can also up-regulate RhoA expression through transcription factor HIF1A. The activation and up-regulation of RhoA synergistically promote gastric cancer metastasis through LIMK/cofilin signaling.
Fig 2: Lyso-PS activates RhoA, cooperates with HIF1A to regulate RhoA expression, promotes invasion of gastric cancer cell.Pull-down assays and western blotting to examine the activated RhoA (GTP-RhoA). A Silencing miR-4646-5p or Abhd16a in Drosha decreased GC cells reduced the activated RhoA, then be restored by lyso-PS (10 μM) administration. B miR-4646-5p and ABHD16A overexpression in gastric cancer cells or exogenous lyso-PS (10 μM) were shown to activate RhoA activity in GC cells with endogenous GPR34, but not in GPR34-silenced or PTX (inhibitor of Gαi, 100 ng/ml, 4 h) treated GC cells. C Chromatin immunoprecipitation assay was conducted using extracts of MGC-803 transfected with ectopic HIF1A or control vector. IgG was used as negative controls (**p < 0.01) (left panel). Luciferase assay to show HIF1A regulating transcriptional activity of RhoA in MGC-803 cells (**p < 0.01) (right panel). D Western blotting to determine HIF1A, PHD3, ABHD16A, and RhoA protein levels in MGC-803 cells with ectopic miR-4646-5p, ectopic HIF1A or silenced PHD3 and the controls, or HIF1A reduced MGC-803 cells with ectopic miR-4646-5p or silenced PHD3. E, F Western blotting to detect p-LIMK and LIMK, p-cofilin and cofilin levels in the above GC cells. G–I Transwell assay to test cell invasion ability of GC cells mentioned in E and F. The histograms show the average invaded cells each view (**p < 0.01).
Fig 3: miR-4646-5p/ABHD16A/Lyso-PS stimulated activation of RhoA trigger LIMK/cofilin signaling to promote GC metastasis in vivo and clinic.A, B Lyso-PS concentration of the mice lung and liver metastasis tissues in subgroups were determined by LC/MS-MS (**p < 0.01). C The change of activated RhoA and RhoA, p-LIMK and LIMK, p-cofilin and cofilin in mice lung and liver metastasis tissues by Western blot. D The relative GPR34 and RhoA levels in gastric tumor tissues from the patients with metastases (M+, n = 20) were compared with the age- and sex-matched patients without metastases (M-, n = 20). E Immunohistochemical staining to detect ABHD16A, RhoA, HIF1A, GPR34, p-LIMK, and p-cofilin levels in metastatic GC tumors or in non- metastatic tumor (magnification, ×200; Scale bar, 100 µm). F Summary chart of ABHD16A regulating and activating RhoA and its downstream signaling. RhoA-mediated GC metastasis closely relates with miR-4646-5p/PHD3/HIF1A mediated upregulation of RhoA and lyso-PS/GPR34 depended activation of RhoA in GC cells.
Supplier Page from Abcam for Anti-GPCR GPR34 antibody